Barbara Pro, MD, Joins the Lurie Cancer Center
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University welcomes medical oncologist Barbara Pro, MD. A distinguished scholar and national leader in the research and treatment of Hodgkin and non-Hodgkin lymphomas (specializing in T-cell lymphoma), Dr. Pro will join the Lurie Cancer Center in September, where she will focus on improving treatment options for patients with all types of lymphomas. Pro has been appointed Professor of Medicine in the Division of Hematology/Oncology at Northwestern University Feinberg School of Medicine.
Pro will also serve as Director of Northwestern Medicine Developmental Therapeutics Institute’s Fellowship Program. The Fellowship Program provides an opportunity for physician-scientists to specialize in the development of novel treatment approaches for cancer. “Barbara is an outstanding physician, scientist and mentor,” said Lurie Cancer Center Director, Leonidas Platanias, MD, PhD. “Her leadership will help us launch the next generation of innovative clinical researchers.”
Pro comes to the Lurie Cancer Center from Thomas Jefferson University and Hospitals in Philadelphia where she was Professor of Medical Oncology, as well as Chief of the Lymphoma Section and Director of the Multidisciplinary Cutaneous Lymphoma Clinic. Her research focus on clinical trials for the application of targeted therapeutic agents is helping to improve the outcome of patients affected with aggressive lymphoma subtypes, and has led to the approval of several novel drugs. “I am looking forward to joining a great institution, an outstanding team of physicians and scientists, and using my expertise in clinical trials and drug development to help advance discovery and treatment of patients with lymphoma,” Dr. Pro said.
Previously, Pro was an attending physician and faculty member at Fox Chase Cancer Center and the University of Texas MD Anderson Cancer Center. She has received numerous professional awards and is an active member of several professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology, and the Lymphoma Research Foundation’s Scientific Advisory Board.
“Barbara’s expertise in moving laboratory research to the clinic--combined with her passion for teaching--will help us shape new approaches to cancer therapy,” said Francis Giles, MD, Deputy Director of the Lurie Cancer Center and Director of Northwestern Medicine Developmental Therapeutics Institute.